• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS INC. ADVIA CHEMISTRY GLUCOSE HEXOKINASE_3 (GLUH_3) REAGENTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS INC. ADVIA CHEMISTRY GLUCOSE HEXOKINASE_3 (GLUH_3) REAGENTS Back to Search Results
Catalog Number 10335891
Device Problem Contamination of Device Ingredient or Reagent (2901)
Patient Problem No Information (3190)
Event Date 02/11/2017
Event Type  malfunction  
Manufacturer Narrative
Siemens healthcare support center (hsc) has reviewed the information and has concluded that there is no siemens method or reagent issue.This was due to an user error.The customer is modifying the ready to use siemens reagent, which is not in accordance with the manufacturer's instructions for use (ifu).The reagent modification that the customer is performing by doubling the amount of reagent by diluting with water is not validated and is not supported by siemens.The cause of the discrepant results is unknown.No further investigation of the device is required.
 
Event Description
The customer of an advia chemistry 2400 glucose hexokinase_3 (gluh_3) reagent contacted a siemens customer care center (ccc) specialist to report discordant results.The customer has been diluting the gluh_3 reagents with water in a 1:1 ratio and using the diluted reagents to run patient samples.The customer has also extended the calibration ranges on the system to allow for a successful calibration.The customer obtained discordant patient results upon repeating some of the patient samples.The original results and repeat results were obtained on diluted reagents.Initial patient results with the diluted reagents have been reported to the physician(s).It is unknown if the repeat results with the diluted reagents have been reported to the physician(s).It is unknown if any medical procedure or treatment was administered to patients due to the discrepant glucose hexokinase results.It is unknown if there was any delay in administering medical procedures or treatments to patients due to the discrepant glucose hexokinase results.
 
Manufacturer Narrative
The initial mdr 2432235-2017-00153 was filed on march 1st, 2017.Additional information (03/09/2017): the customer provided additional information on the glucose hexokinase_3 (gluh_3) reagent lot that was used and sid numbers for the gluh_3 data.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CHEMISTRY GLUCOSE HEXOKINASE_3 (GLUH_3) REAGENTS
Type of Device
ADVIA CHEMISTRY GLUCOSE HEXOKINASE_3 (GLUH_3) REAGENTS
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS INC.
511 benedict avenue
tarrytown NY 10591
Manufacturer (Section G)
RANDOX LABORATORIES LTD.
registration # 8020890
55 diamond road
crumlin, county antrim BT29 4QY
UK   BT29 4QY
Manufacturer Contact
devyani chaudhuri
511 benedict avenue
tarrytown, NY 10591
9145242637
MDR Report Key6367663
MDR Text Key68605592
Report Number2432235-2017-00153
Device Sequence Number1
Product Code CFR
Combination Product (y/n)N
Reporter Country CodeBR
PMA/PMN Number
K101854
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,user facility
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 03/30/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/01/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number10335891
Device Lot Number374718
Is the Reporter a Health Professional? No
Date Manufacturer Received03/09/2017
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-